BOT 1.59% 32.0¢ botanix pharmaceuticals ltd

Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,544 Posts.
    lightbulb Created with Sketch. 318
    This has been one hell of a haul and often exhausting as most can testify. Two phase 2 trials where we are world leading. Sooner or later the potential will be revealed but in the interim there are many forces at play. However only two really count.

    Supply de man.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
32.0¢
Change
0.005(1.59%)
Mkt cap ! $707.4M
Open High Low Value Volume
31.5¢ 32.5¢ 31.0¢ $1.169M 3.655M

Buyers (Bids)

No. Vol. Price($)
9 274982 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 48600 2
View Market Depth
Last trade - 16.10pm 22/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.